A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery

Journal of International Medical Research

Volumn 39, Issue 2, 2011, Pages 399-407

  Park, S K ^a   Cho, E J ^a  

^a Bupyeong gu   (South Korea)

Author keywords

Gynaecological laparoscopic surgery; Ondansetron; Palonosetron; Postoperative nausea and vomiting (PONV)

Indexed keywords

ONDANSETRON; PALONOSETRON;

ADULT; ARTICLE; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GYNECOLOGIC SURGERY; HEADACHE; HUMAN; LAPAROSCOPIC SURGERY; MYALGIA; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; VISUAL ANALOG SCALE;

EID: 79955675461     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900207     Document Type: Article

References (32)

1. Watcha MF, White PF: Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-184.
2. Muchatuta NA, Paech MJ: Management of postoperative nausea and vomiting: focus on palonosetron. Ther Clin Risk Manag 2009; 5: 21-34.
3. Gan TJ: Risk factors for postoperative nausea and vomiting. Anesth Analg 2006; 102: 1884-1898.
4. Apfel CC, Läärä E, Koivuranta M, et al: A simplified risk score for predicting postoperative nausea and vomiting: conclusions from crossvalidations between two centers. Anesthesiology 1999; 91: 693-700.
5. Wong EH, Clark R, Leung E, et al: The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro. Br J Pharmacol 1995; 114: 851-859.
6. Stoltz R, Cyong JC, Shah A, et al: Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects. J Clin Pharmacol 2004; 44: 520-531.
7. Kovac AL, Eberhart L, Kotarski J, et al: A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg 2008; 107: 439-444.
8. Aapro MS, Grunberg SM, Manikhas GM, et al: A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 2006; 17: 1441-1449.
9. Sweitzer BJ: Overview of preoperative assessment and management. In: Anesthesiology (Longnecker DE, ed.). Columbus: McGraw-Hill, 2008; pp 42-43.
10. Yun MJ, Kim YH, Kim AR: Comparison of azasetron and ondansetron for preventing postoperative nausea and vomiting in patients undergoing gynecological laparoscopic surgery. Yonsei Med J 2010; 51: 88-92.
11. Gupta A, Wu CL, Elkassabany N, et al: Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery?: A systematic review of randomized controlled trials. Anesthesiology 2003; 99: 488-495.
12. Habib AS, Gan TJ: Evidence-based management of postoperative nausea and vomiting: a review. Can J Anesth 2004; 51: 326-341.
13. Paventi S, Santevecchi A, Ranieri R: Efficacy of a single-dose ondansetron for preventing postoperative nausea and vomiting after laparoscopic cholecystectomy with sevoflurane and remifentanil infusion anaesthesia. Eur Rev Med Pharmacol Sci 2001; 5: 59-63.
14. Gralla R, Lichinitser M, Van Der Vegt S, et al: Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 2003; 14: 1570-1577.
15. Kovac AL: Prevention and treatment of postoperative nausea and vomiting. Drugs 2000; 59: 213-243.
16. Koivuranta M, Ala-Kokko TI, Jokela R, et al: Comparison of ondansetron and tropisetron combined with droperidol for the prevention of emesis in women with a history of postoperative nausea and vomiting. Eur J Anaesthesiol 1999; 16: 390-395.
17. Sinclair DR, Chung F, Mezei G: Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91: 109-118.
18. Newberry NR, Watkins CJ, Sprosen TS, et al: BRL 46470 potently antagonizes neural responses activated by 5-HT3 receptors. Neuropharmacology 1993; 32: 729-735.
19. Tramer MR, Reynolds DJ, Moore RA, et al: Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebocontrolled trials. Anesthesiology 1997; 87: 1277-1289.
20. Gan TJ: Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy. CNS Drugs 2007; 21: 813-833.
21. Kovac AL: Prophylaxis of postoperative nausea and vomiting: controversies in the use of serotonin 5-hydroxytryptamine subtype 3 receptor antagonists. J Clin Anesth 2006; 18: 304-318.
22. Apfel CC, Kranke P, Eberhart LH, et al: Comparison of predictive models for postoperative nausea and vomiting. Br J Anaesth 2000; 88: 234-240.
23. Scuderi PE, James RL, Harris L, et al: Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 2000; 91: 1408-1414.
24. Paech MJ, Lee BH, Evans SF: The effect of anaesthetic technique on postoperative nausea and vomiting after day-case gynaecological laparoscopy. Anaesth Intensive Care 2002; 30: 153-159.
25. Gan TJ, Coop A, Philip BK, et al: A randomized, double-blind study of granisetron plus dexamethasone versus ondansetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing abdominal hysterectomy. Anesth Analg 2005; 101: 1323-1329.
26. Fujii Y, Saitoh Y, Tanaka H, et al: Prophylactic antiemetic therapy with granisetron-droperidol combination in patients undergoing laparoscopic cholecystectomy. Can J Anaesth 1998; 45: 541-544.
27. Elhakim M, Nafie M, Mahmoud K, et al: Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 2002; 49: 922-926.
28. Candiotti KA, Kovac AL, Melson TI, et al: A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting. Anesth Analg 2008; 107: 445-451.
29. 14C]-palonosetron in healthy human volunteers. Biopharm Drug Dispos 2004; 25: 329-337.
30. 3 antagonists with dexamethasone or droperidol for prevention of PONV. Ann Pharmacother 2006; 40: 856-872.
31. Ho KY, Gan TJ: Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting. Curr Opin Anaesthesiol 2006; 19: 606-611.
32. Navari RM: Palonosetron: a second generation 5-hydroxytryptamine 3 receptor antagonist. Expert Opin Drug Metab Toxicol 2009; 12: 1577-1586.